ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)
Public ClinicalTrials.gov record NCT05006885. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to assess the safety and tolerability of ALT-801 in diabetic and non-diabetic subjects with overweight and obese and non-alcoholic fatty liver disease (NAFLD).
Study identification
- NCT ID
- NCT05006885
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 95 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2021 (Actual)
- Primary completion
- Aug 17, 2022 (Actual)
- Completion
- Aug 17, 2022 (Actual)
- Last update posted
- Jul 27, 2023
2021 – 2022
United States locations
- U.S. sites
- 15
- U.S. states
- 6
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Headlands Research Scottsdale | Scottsdale | Arizona | 85260 | — |
| QLMC | Tucson | Arizona | 85712 | — |
| Catalina Research Institute | Montclair | California | 91763 | — |
| Clinical Trials Research | Sacramento | California | 95648 | — |
| Panax Clinical Research | Miami Lakes | Florida | 33014 | — |
| Covenant Research and Clinics | Sarasota | Florida | 34240 | — |
| Headlands Research Sarasota | Sarasota | Florida | 34243 | — |
| Wake Research CRCN | Las Vegas | Nevada | 89106 | — |
| Accelemed Research Institute | Austin | Texas | 78745 | — |
| Pinnacle Research | Austin | Texas | 78757 | — |
| South Texas Research Institute | Brownsville | Texas | 78520 | — |
| South Texas Research Institute | Edinburg | Texas | 78539 | — |
| Diagnostics Research Group | San Antonio | Texas | 78229 | — |
| Pinnacle Research | San Antonio | Texas | 78229 | — |
| Cognitive Clinical Trials | Salt Lake City | Utah | 84117 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05006885, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2023 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05006885 live on ClinicalTrials.gov.